See more : Hop-On Inc. (HPNN) Income Statement Analysis – Financial Results
Complete financial analysis of MD Medical Group Investments Plc (MDMG.ME) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MD Medical Group Investments Plc, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Enlight Corporation (2438.TW) Income Statement Analysis – Financial Results
- Eldeco Housing and Industries Limited (ELDEHSG.BO) Income Statement Analysis – Financial Results
- Dali Foods Group Company Limited (3799.HK) Income Statement Analysis – Financial Results
- Uzabase, Inc. (UBAZF) Income Statement Analysis – Financial Results
- Jiu Han System Technology Co., Ltd. (6903.TWO) Income Statement Analysis – Financial Results
MD Medical Group Investments Plc (MDMG.ME)
About MD Medical Group Investments Plc
MD Medical Group Investments Plc, an investment holding company, provides healthcare services for women and children in Russia. It offers a range of services in the areas of obstetrics and gynaecology, fertility and IVF treatment, and pediatrics, as well as diagnostics, urology, radiology, surgery, traumatology, rehabilitation, cardiology, oncology, endovascular, laboratory examinations, and other services. The company also retails pharmaceutics; and provides assistance services. As of March 28, 2022, it managed 47 healthcare facilities, including 8 hospitals and 39 out-patient clinics in 27 cities and 25 regions. The company was founded in 2006 and is based in Nicosia, Cyprus. MD Medical Group Investments Plc is a subsidiary of MD Medical Holding Limited.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.22B | 25.22B | 19.13B | 16.16B | 14.94B | 13.76B | 12.18B | 9.51B | 7.20B | 5.67B | 4.06B | 2.91B | 2.04B | 1.79B |
| Cost of Revenue | 15.43B | 15.23B | 12.01B | 10.38B | 9.39B | 8.36B | 7.40B | 5.92B | 4.23B | 3.39B | 2.01B | 1.46B | 956.46M | 851.21M |
| Gross Profit | 9.79B | 9.99B | 7.13B | 5.78B | 5.55B | 5.40B | 4.78B | 3.59B | 2.97B | 2.28B | 2.05B | 1.44B | 1.09B | 938.35M |
| Gross Profit Ratio | 38.83% | 39.60% | 37.25% | 35.79% | 37.15% | 39.23% | 39.24% | 37.75% | 41.26% | 40.25% | 50.43% | 49.66% | 53.21% | 52.43% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 240.00M | 197.36M | 213.23M | 224.45M | 700.41M | 623.85M | 530.19M | 491.99M | 528.91M | 416.36M | 217.09M | 245.61M | 134.62M | 106.45M |
| Selling & Marketing | 971.94M | 851.13M | 690.54M | 643.17M | 96.26M | 128.66M | 149.74M | 121.58M | 80.34M | 78.15M | 36.04M | 0.00 | 0.00 | 0.00 |
| SG&A | 1.21B | 1.05B | 903.78M | 867.62M | 796.67M | 752.51M | 679.93M | 613.57M | 609.25M | 494.51M | 253.13M | 245.61M | 134.62M | 106.45M |
| Other Expenses | 3.61B | 2.25B | 1.90B | 1.78B | 1.63B | 1.42B | 1.38B | 1.20B | 825.65M | 630.84M | 234.49M | 5.23M | -3.60M | 1.79M |
| Operating Expenses | 4.82B | 3.30B | 2.81B | 2.65B | 2.43B | 2.17B | 2.06B | 1.81B | 1.43B | 1.13B | 487.62M | 250.84M | 131.02M | 108.24M |
| Cost & Expenses | 20.25B | 18.53B | 14.81B | 13.03B | 11.81B | 10.53B | 9.46B | 7.73B | 5.67B | 4.51B | 2.50B | 1.71B | 1.09B | 959.46M |
| Interest Income | 355.83M | 93.68M | 110.80M | 111.73M | 76.70M | 58.67M | 46.31M | 47.36M | 41.66M | 65.15M | 13.14M | 628.00K | 363.00K | 332.00K |
| Interest Expense | 379.45M | 493.48M | 480.76M | 505.60M | 384.78M | 291.19M | 301.82M | 367.53M | 292.24M | 279.21M | 27.22M | 30.14M | 34.20M | 117.46M |
| Depreciation & Amortization | 1.67B | 1.79B | 1.66B | 1.64B | 1.19B | 1.04B | 946.39M | 880.68M | 546.82M | 427.92M | 134.13M | 99.29M | 131.88M | 125.37M |
| EBITDA | 6.77B | 8.35B | 6.34B | 4.77B | 4.43B | 4.11B | 3.49B | 3.05B | 2.23B | 1.54B | 1.68B | 1.30B | 1.09B | 948.83M |
| EBITDA Ratio | 26.86% | 33.35% | 32.24% | 29.54% | 28.60% | 28.30% | 26.90% | 30.36% | 29.30% | 24.95% | 37.96% | 43.35% | 51.40% | 51.45% |
| Operating Income | 4.97B | 6.62B | 4.50B | 3.13B | 3.12B | 3.23B | 2.72B | 1.78B | 1.54B | 1.16B | 1.56B | 1.19B | 956.70M | 830.11M |
| Operating Income Ratio | 19.70% | 26.26% | 23.54% | 19.40% | 20.92% | 23.45% | 22.36% | 18.67% | 21.33% | 20.42% | 38.42% | 41.03% | 46.80% | 46.39% |
| Total Other Income/Expenses | -242.97M | -463.70M | -166.12M | -377.30M | -267.01M | -444.96M | -484.60M | 29.90M | -141.08M | -322.71M | -41.29M | 2.04M | -35.35M | -124.11M |
| Income Before Tax | 4.73B | 6.16B | 4.34B | 2.76B | 2.86B | 2.78B | 2.24B | 1.80B | 1.39B | 835.42M | 1.52B | 1.20B | 921.36M | 706.00M |
| Income Before Tax Ratio | 18.74% | 24.42% | 22.67% | 17.06% | 19.13% | 20.22% | 18.38% | 18.99% | 19.37% | 14.73% | 37.40% | 41.10% | 45.07% | 39.45% |
| Income Tax Expense | 7.59M | 15.24M | 4.77M | -29.58M | 26.14M | 76.91M | -38.31M | 34.47M | 75.13M | 71.87M | -19.18M | 271.11M | 186.56M | 142.38M |
| Net Income | 4.56B | 6.00B | 4.20B | 2.64B | 2.67B | 2.49B | 2.07B | 1.60B | 1.20B | 636.15M | 1.40B | 859.98M | 697.99M | 535.44M |
| Net Income Ratio | 18.08% | 23.80% | 21.93% | 16.32% | 17.88% | 18.09% | 16.96% | 16.87% | 16.60% | 11.21% | 34.46% | 29.58% | 34.15% | 29.92% |
| EPS | 60.70 | 79.91 | 55.86 | 35.11 | 35.61 | 33.23 | 27.58 | 21.41 | 15.94 | 8.47 | 21.46 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 60.70 | 79.91 | 55.86 | 35.11 | 35.61 | 33.23 | 27.58 | 21.41 | 15.94 | 8.47 | 21.46 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 75.13M | 75.13M | 75.13M | 75.12M | 75.02M | 74.90M | 74.90M | 74.90M | 75.03M | 75.13M | 65.22M | 72.13B | 72.13B | 72.13B |
| Weighted Avg Shares Out (Dil) | 75.13M | 75.13M | 75.13M | 75.12M | 75.02M | 74.90M | 74.90M | 74.90M | 75.03M | 75.13M | 65.22M | 72.13B | 72.13B | 72.13B |
Source: https://incomestatements.info
Category: Stock Reports